Synthesis and antimalarial evaluation of novel isocryptolepine derivatives

Bioorg Med Chem. 2011 Dec 15;19(24):7519-25. doi: 10.1016/j.bmc.2011.10.037. Epub 2011 Oct 20.

Abstract

A series of mono- and di-substituted analogues of isocryptolepine have been synthesized and evaluated for in vitro antimalarial activity against chloroquine sensitive (3D7) and resistant (W2mef) Plasmodium falciparum and for cytotoxicity (3T3 cells). Di-halogenated compounds were the most potent derivatives and 8-bromo-2-chloroisocryptolepine displayed the highest selectivity index (106; the ratio of cytotoxicity (IC(50)=9005 nM) to antimalarial activity (IC(50)=85 nM)). Our evaluation of novel isocryptolepine compounds has demonstrated that di-halogenated derivatives are promising antimalarial lead compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Animals
  • Antimalarials / chemical synthesis
  • Antimalarials / chemistry*
  • Antimalarials / pharmacology*
  • Chloroquine / pharmacology
  • Humans
  • Indole Alkaloids / chemical synthesis
  • Indole Alkaloids / chemistry*
  • Indole Alkaloids / pharmacology*
  • Malaria, Falciparum / drug therapy
  • Mice
  • Plasmodium falciparum / drug effects*
  • Quinolines / chemical synthesis
  • Quinolines / chemistry*
  • Quinolines / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antimalarials
  • Indole Alkaloids
  • Quinolines
  • cryptolepine
  • Chloroquine